| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56abb7a905b2aba4c53d3d3debee8c14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
1992-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c88ad329718b3ed5b42fc0f72f43be1 |
| publicationDate |
1992-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5175189-A |
| titleOfInvention |
Treatment of ocular hypertension with a synergistic combination for ophthalmic use |
| abstract |
A method for treatment of ocular hypertension which comprises ocularly administering, to a subject in need of such treatment, an oculo-hypotensively synergistic combination of (a) a 15-ketoprostaglandin or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable ester thereof, and (b) a sympathomimetic agent in an amount effective in treatment of ocular hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8686035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085248-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085248-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003220396-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004198829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008033036-A1 |
| priorityDate |
1990-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |